J&J agrees Stelara deals with generics
Deal thought to be aimed at helping pharma giant attain sales target as patents start to expire | Israeli drugmaker will join with Icelandic firm to unveil a copycat version of blockbuster treatment by 2025.
Boston Scientific secures nearly $160m in clips patents feud
Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country.
Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech
Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies.
Teleflex secures win over Medtronic in catheter patent case
Medtronic’s claims of “obviousness” over cardiologist’s device rejected | US Federal Circuit upholds Teleflex’s catheter technology patents.
10x escalates genomics patents dispute at the UPC
Biotech hoping for ‘pan-European injunctive relief’ | Vizgen CEO says lawsuits an ‘attempt to undermine innovation’.
Cooley appoints ‘first-rate’ life sciences partner trio
The ‘formidable’ three bring 52 years’ experience from Fish & Richardson collectively | ‘Extensive’ patent trial background includes branded Hatch-Waxman litigation.
Indivior avoids multi-state antitrust trial with $100m payout
Case involved the alleged monopolisation of an opioid addiction treatment | More than 40 attorneys general had filed complaints against the pharma company.
Abbott sues former employee for alleged trade secrets theft
Ex-scientist faces lawsuit for allegedly downloading thousands of files before leaving for a rival | Abbott seeks damages for ‘flagrant misconduct’ brought to its attention by successive employer.
‘A new dawn for patents’: the UPC opens its doors
A project decades in the making, the Unified Patent Court and Unitary Patent promise to change the European IP landscape, writes Marisa Woutersen.
Moderna and Pfizer face fresh suits over COVID-19 vaccine
A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.
